These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21752876)

  • 21. Classification of prostanoid receptors.
    Gardiner PJ
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():110-8. PubMed ID: 2144686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostamides (prostaglandin-ethanolamides) and their pharmacology.
    Woodward DF; Liang Y; Krauss AH
    Br J Pharmacol; 2008 Feb; 153(3):410-9. PubMed ID: 17721551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Function of prostanoid receptors: studies on knockout mice.
    Kobayashi T; Narumiya S
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():557-73. PubMed ID: 12432943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The constitutive activity of ghrelin receptors is decreased by co-expression with vasoactive prostanoid receptors when over-expressed in human embryonic kidney 293 cells.
    Chow KB; Leung PK; Cheng CH; Cheung WT; Wise H
    Int J Biochem Cell Biol; 2008; 40(11):2627-37. PubMed ID: 18573679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of prostanoid receptors in hepatocytes, Kupffer cells, sinusoidal endothelial cells and stellate cells of rat liver.
    Fennekohl A; Schieferdecker HL; Jungermann K; Püschel GP
    J Hepatol; 1999 Jan; 30(1):38-47. PubMed ID: 9927149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostanoid receptor subtypes: new targets for OAB drugs?
    Andersson KE
    J Urol; 2009 Nov; 182(5):2099-100. PubMed ID: 19758658
    [No Abstract]   [Full Text] [Related]  

  • 27. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
    Hirano Y; Shichijo M; Deguchi M; Nagira M; Suzuki N; Nishitani Y; Hattori M; Arimura A
    Eur J Pharmacol; 2007 Mar; 560(1):81-8. PubMed ID: 17307163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandins in the kidney: developments since Y2K.
    Nasrallah R; Clark J; Hébert RL
    Clin Sci (Lond); 2007 Oct; 113(7):297-311. PubMed ID: 17760567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular biology and ocular distribution of prostanoid receptors.
    Woodward DF; Regan JW; Lake S; Ocklind A
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S15-21. PubMed ID: 9154272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostanoid receptor subtypes.
    Tsuboi K; Sugimoto Y; Ichikawa A
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():535-56. PubMed ID: 12432942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin D(2) induces contraction via thromboxane A(2) receptor in rat liver myofibroblasts.
    Maruyama T; Murata T; Ayabe S; Hori M; Ozaki H
    Eur J Pharmacol; 2008 Sep; 591(1-3):237-42. PubMed ID: 18586024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions.
    Bäck M; Dahlén SE; Drazen JM; Evans JF; Serhan CN; Shimizu T; Yokomizo T; Rovati GE
    Pharmacol Rev; 2011 Sep; 63(3):539-84. PubMed ID: 21771892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostanoid receptors in the human vascular wall.
    Norel X
    ScientificWorldJournal; 2007 Sep; 7():1359-74. PubMed ID: 17767355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostanoid receptors in anagen human hair follicles.
    Colombe L; Michelet JF; Bernard BA
    Exp Dermatol; 2008 Jan; 17(1):63-72. PubMed ID: 18005048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist.
    Wright DH; Metters KM; Abramovitz M; Ford-Hutchinson AW
    Br J Pharmacol; 1998 Apr; 123(7):1317-24. PubMed ID: 9579725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension.
    Tang EH; Vanhoutte PM
    Physiol Genomics; 2008 Feb; 32(3):409-18. PubMed ID: 18056786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostanoid receptor antagonists: development strategies and therapeutic applications.
    Jones RL; Giembycz MA; Woodward DF
    Br J Pharmacol; 2009 Sep; 158(1):104-45. PubMed ID: 19624532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.
    Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Lönnroth C; Lundholm K
    Acta Oncol; 2007; 46(8):1107-12. PubMed ID: 17943472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human EP2 prostanoid receptors exhibit more constraints to mutations than human DP prostanoid receptors.
    Tanimoto J; Fujino H; Takahashi H; Murayama T
    FEBS Lett; 2015 Mar; 589(6):766-72. PubMed ID: 25681680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostanoid DP receptor antagonists suppress symptomatic asthma-like manifestation by distinct actions from a glucocorticoid in rats.
    Hirano Y; Shichijo M; Ikeda M; Kitaura M; Tsuchida J; Asanuma F; Yanagimoto T; Furue Y; Imura K; Yasui K; Arimura A
    Eur J Pharmacol; 2011 Sep; 666(1-3):233-41. PubMed ID: 21596028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.